GREEN DAVID 4

4 · Biostage, Inc. · Filed Mar 2, 2023

Form 4

Period: 2023-02-28

DirectorChief Executive Officer

Transactions

Award
Stock Option (right to buy)
2023-02-28+38,773→ 38,773 total
Exercise: $6.00Exp: 2033-02-28→ Common Stock, par value $0.01 per share (38,773 underlying)
Award
Stock Option (right to buy)
2023-02-28+732,384→ 732,384 total
Exercise: $6.00Exp: 2033-02-28→ Common Stock, par value $0.01 per share (732,384 underlying)
Award
Stock Option (right to buy)
2023-02-28+39,662→ 39,662 total
Exercise: $6.00Exp: 2033-02-28→ Common Stock, par value $0.01 per share (39,662 underlying)

Footnotes (3)

[F1]This stock option grant was fully exercisable as of date of grant.
[F2]The non-qualified stock option was scheduled to vest during the twelve months following the grant date, but in connection with the Issuer's transition to a new CEO as of March 1, 2023, this option has been forfeited.
[F3]The non-qualified stock option was scheduled to vest monthly in thirty-six equal monthly installments on each monthly anniversary of February 28, 2023, but in connection with the Issuer's transition to a new CEO as of March 1, 2023, 488,256 shares underlying this option have been forfeited, and subject to the Reporting Person's execution of a customary release, the remaining 244,128 shares will be deemed fully vested and exercisable.

Documents

1 file